Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects
Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects
Comprehensive Screening of Multiple Prohibited Substances in Chinese Traditional Patent Medicine by UHPLC‐Q‐Orbitrap HRMS
An ultrahigh performance liquid chromatography-quadrupole-orbitrap high-resolution mass spectrometry has been established for rapid screening of doping agents in Chinese traditional…
Drug Trials Snapshot: VANRAFIA
VANRAFIA is an endothelin type A receptor antagonist that is indicated to reduce proteinuria in adults with primary immunoglobulin A…
FDA and Kratom
Kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive in…
Hydroxie, LLC – 709661 – 06/25/2025
Unapproved New Drug/Human Food/Adulterated
Royal Diamond Imports, Inc. – 709540 – 06/25/2025
Unapproved New Drug/Misbranded
7Tabz Retail, LLC – 709546 – 06/25/2025
Unapproved New Drugs
Revitalize Energy, Inc. – 712417 – 07/09/2025
Unapproved New Drugs/Misbranded
EyeTech One, LLC – 712438 – 07/09/2025
Unapproved New Drugs/Misbranded
Covalent Medical – 695839 – 07/09/2025
Unapproved New Drugs/Misbranded